Invasive lobular carcinoma (ILC) begins when abnormal cells form in your breast and spread to other parts of your breast tissue. ILC is the second most common type of breast cancer, making up about 10% of all breast cancer cases. The condition is sometimes called infiltrating lobular carcinoma.
Invasive lobular carcinoma tends to grow in a single-file pattern of cells compared to invasive ductal carcinoma (IDC), which more commonly forms a mass or lump. ILC can be detected under the microscope by the lack of a specific protein called E-cadherin.
Women who are 55 or over are most likely to develop invasive lobular carcinoma. Men can develop ILC, too, though it’s rare. Transwomen have a higher risk of developing breast cancer than cisgender men. Conversely, transmen have a lower risk compared to cisgender women.
Unlike invasive ductal carcinoma (IDC), invasive lobular carcinoma usually occurs later in life. Many people are in their early 60s at the time of their diagnosis.
About 10% of all breast cancers are invasive lobular carcinomas. It’s considered the second most common type of breast cancer, just after IDC. ILC is more common in women than men. It makes up about 2% of male breast cancers.
No. Invasive lobular carcinoma is usually slow-growing.
Invasive lobular carcinoma is divided into four stages. Staging is based on several factors, including the size of the tumor, where it’s located and how far it has spread:
Like most breast cancers, invasive lobular carcinoma may not cause any symptoms in the early stages. However, some people may notice these warning signs:
Unlike other types of breast cancer, ILC may not result in an obvious lump or bump in your breast. The affected area may feel different from the surrounding tissue. These symptoms are also similar to symptoms of other serious conditions, such as inflammatory breast cancer (IBC). Therefore, you should contact your healthcare provider immediately if you notice anything unusual.
Experts know that ILC occurs when cells in your breast develop mutations in their DNA. But they aren’t exactly sure what causes those mutations to occur. There are factors that could increase your risk for invasive lobular carcinoma, including:
The term “invasive” means that the cancer started in the lobules or ducts of the breast but spread to surrounding breast tissue. Eventually, the cancer can also spread to lymph nodes, organs and other areas throughout your body.
ILC first spreads from your breast tissue to nearby lymph nodes. After that, it most commonly spreads to your liver, bone, lungs or brain.
In most cases, invasive lobular carcinoma is detected during a routine mammogram or by physical exam. During this exam, your healthcare provider will feel for lumps, bumps, skin thickening or other abnormalities in your breast. They may also order other tests, including:
There are two main categories of ILC treatment — local and systemic. Local treatments target the tumor and the surrounding areas, while systemic treatments travel through your body to kill any cancer cells that have spread throughout it.
Local treatments include:
Systemic treatments include:
As with any cancer treatment, people who undergo treatment for invasive lobular carcinoma may experience some side effects. These side effects depend on the type of treatment you undergo, how advanced your cancer is, your body’s healing capacity and other factors.
People who undergo surgery for invasive lobular carcinoma may develop infections, blood clots, allergies to anesthesia or other complications. Radiation therapy is often associated with fatigue, nausea and skin irritation.
People who undergo chemotherapy may develop several side effects, including:
For people receiving anti-hormone therapy, the most common side effects are hot flashes, joint pain, weight changes, mood changes, vaginal dryness or discharge, and a decrease in sexual desire.
Healing times can vary for each individual. If you’ve had surgery, recovery usually takes about two to four weeks. Chemotherapy, radiation therapy and targeted therapy may take several weeks to several months depending on your specific situation. Ask your healthcare provider what to expect in terms of recovery.
Although you can’t prevent invasive lobular carcinoma altogether, there are things you can do to reduce your risk. For example:
Fortunately, ILC is a slow-growing cancer, so there is the opportunity to catch it in the early stages when treatment is most successful. Invasive lobular carcinoma prognosis depends on several factors, including the size of the tumor, its location and whether or not it has spread. If you’ve recently been diagnosed with ILC, talk with your healthcare provider about treatment options as soon as possible.
Yes. Invasive lobular carcinoma can be cured when caught and treated early.
The five-year survival rate for invasive lobular carcinoma is high compared to other types of cancer — nearly 100% when treated early. If the cancer has spread to nearby tissues, the five-year survival rate is about 93%. If it has metastasized to other areas of your body, the five-year survival rate is 22%.
It’s important to note that survival rates can’t tell you how long you’ll live. These estimates are based on people who have had invasive lobular carcinoma in the past. To learn more about your unique case, talk to your healthcare provider.
Any time you notice any sudden or unusual changes in your breast tissue, you should schedule a consultation with your healthcare provider. They can run tests to determine if you have breast cancer. If you’re already undergoing treatment for ILC, call your healthcare provider if you develop any worrisome symptoms, such as chest pain, confusion, chills, high fever, shortness of breath (dyspnea) bone pain or abdominal pain.
If you’ve been diagnosed with invasive lobular carcinoma, you’ll want to gather as much information as possible. Here are some questions you can ask your healthcare provider:
Any time you notice any sudden or unusual changes in your breast tissue, you should schedule a consultation with your healthcare provider. They can run tests to determine if you have breast cancer. If you’re already undergoing treatment for invasive lobular carcinoma, call your provider if you develop any worrisome symptoms, such as chest pain, confusion, chills, high fever, shortness of breath (dyspnea) bone pain or abdominal pain.
If you’ve been diagnosed with invasive lobular carcinoma, you’ll want to gather as much information as possible. Here are some questions you can ask your healthcare provider: